Updater Services IPO Opens on September 25 with Price Band of Rs 280-300

| Leave a Comment | IPO

Mumbai-based facility management company Updater Services is launching its initial public offering (IPO) on September 25, 2023, with a price band of Rs 280-300 per share.

The IPO comprises a fresh issue of shares worth Rs 400 crore and an offer-for-sale (OFS) of 80 lakh shares worth Rs 240 crore by three shareholders.

The company plans to use the fresh issue proceeds to repay debt, meet working capital requirements, and fund inorganic initiatives.

The IPO is open for subscription to retail investors, high networth individuals (HNIs), and qualified institutional buyers (QIBs).

Retail investors can bid for a minimum of 50 shares and in multiples of 50 shares thereafter.

The issue will close on September 27, 2023, and the shares are expected to list on the BSE and NSE on October 9, 2023.

Key takeaways:

  • Updater Services is the second-largest player in the integrated facilities management market in India.
  • The company recorded a net profit of Rs 34.6 crore for the year ended March 2023, with revenue of Rs 2,104.9 crore.
  • The IPO is priced at a price-to-book value (P/BV) of 101.05 based on the company’s net asset value (NAV) of Rs 3.81.
  • The company has a strong track record of profitability and growth.
  • The IPO is open to all categories of investors, with a minimum lot size of 50 shares.

Investors should carefully consider their risk appetite and investment objectives before investing in the IPO


Related News

  • 22 Sep

    Samhi Hotels Stock Lists with 6.75% Premium, Analysts Recommend Booking Profits

    Samhi Hotels stock made a weak debut on the stock exchanges, listing at a premium of just 6.75% over the IPO price. Several analysts have recommended booking profits in the stock, citing its loss-making status and negative net worth.

  • 22 Sep

    Signature Global IPO Subscribed 11.88 Times on Final Day

    The Signature Global IPO was subscribed 11.88 times on the final day of bidding. The company will use the proceeds to repay debt and for land acquisitions and general corporate purposes. The IPO is expected to list on October 4, but this may change due to the new timeline of T+3.

  • 22 Sep

    Sai Silks IPO Oversubscribed 4.4 Times on Final Day of Bidding

    Sai Silks IPO was oversubscribed 4.4 times on the final day of bidding, with qualified institutional buyers and high networth individuals supporting the issue on closing day. The net fresh issue proceeds will be utilized by the company mainly for the setting up of 30 new stores, two warehouses, working capital requirements and repaying debts. The trading in its equity shares will commence with effect from October 4, as per the IPO schedule.

  • 22 Sep

    Pharma company Valiant Laboratories to go public on September 27

    Pharma company Valiant Laboratories is going public on September 27 at a price band of Rs 133-140 per share. The company plans to raise Rs 152.46 crore via the IPO. Proceeds will be used to fund the expenditure for setting up a manufacturing facility for speciality chemicals and for working capital requirements and general corporate purposes. Valiant Laboratories is a Mumbai-based API and bulk drug manufacturing company with a focus on Paracetamol. It is owned by the promoters including Dhanvallabh Ventures LLP, which holds 62.5 percent shareholding. Valiant Organics, the listed entity on the BSE and NSE, is the promoter of Dhanvallabh Ventures LLP with 73.15 percent stake.

  • 21 Sep

    Unihealth Consultancy makes tepid debut on NSE Emerge

    Unihealth Consultancy, a healthcare service provider, made a tepid debut on the NSE Emerge platform on September 21, listing at Rs 135, a 2.2 percent premium over its issue price of Rs 132. The stock was trading at Rs 137.30 at 11.40 am. The company has a number of positives going for it, such as its strong growth potential, its diversified business model, and its focus on the African market. However, investors who are considering investing in Unihealth Consultancy should carefully consider the company's fundamentals, the current market conditions, and their own risk appetite before making a decision.

Leave a Reply

Your email address will not be published. Required fields are marked *